The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

Abstract Patients with chronic kidney diseases (CKD) are often treated with antiplatelets due to aberrant haemostasis. This study aimed to evaluate the bleeding risk with CKD patients undergoing pentoxifylline (PTX) treatment with/without aspirin. In this retrospective study, we used Taiwan’s Nation...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing-Hung Fang, Yi-Chen Chen, Chung-Han Ho, Jui-Yi Chen, Chung-Hsi Hsing, Fu-Wen Liang, Chia-Chun Wu
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/a770523e0df6497e8fc1816ef4e748e7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items